| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Qun Zhao CEO | XSHE Exchange | CNE1000016D0 ISIN |
| CN Country | 1,196 Employees | 11 Jul 2019 Last Dividend | 8 Jul 2016 Last Split | 19 Aug 2011 IPO Date |
ShanXi C&Y Pharmaceutical Group Co.,LTD. is a prominent enterprise in the pharmaceutical sector, with a focus on the research, development, production, and sale of a wide range of medicine and health food products. Originally known as Shanxi C&Y Pharmaceutical Co., Ltd., it underwent a name change in September 2014 to better reflect its expansion and diversification in the pharmaceutical arena. Since its establishment in 2005, ShanXi C&Y Pharmaceutical Group Co.,LTD. has committed itself to producing high-quality pharmaceutical products and services. With headquarters in Datong, China, the company leverages its robust capabilities in R&D and manufacturing to address the diverse needs of patients and the healthcare industry at large.
The company’s extensive product portfolio and services include:
In addition to its comprehensive range of pharmaceutical products, ShanXi C&Y Pharmaceutical Group Co.,LTD. also offers a variety of medical and health services which include medical diagnosis, DNA gene preservation services, and pregnancy environment testing services. These services are geared towards enhancing overall health, aiding in disease prevention, and ensuring well-being across different life stages.